Amazon Web Services, an Amazon.com, Inc. company and Memorial Sloan Kettering Cancer Center, a leading global cancer center, have announced a collaboration harnessing the power of Artificial Intelligence, high performance computing, and other cloud technology to accelerate breakthroughs in cancer.
With cancer deaths projected to reach 15 million annually by 2040, uniting MSK’s research and clinical expertise with AWS’s advanced cloud technologies is a bold step towards addressing one of the world’s most pressing health challenges.
In keeping with MSK’s mission of Ending Cancer for Life, AWS will provide the advanced tools and technology for MSK to unlock insights derived from years of clinical research and cancer treatment. This groundbreaking effort will incorporate deidentified genomic, imaging, and clinical data to create a powerful source for MSK’s AI driven cancer research and personalized treatment development. The goal will be to build a high-quality, up-to-date longitudinal data resource for cancer research at MSK, as well as serve as a source for validating and improving cancer research with partners.
“MSK’s collaboration with AWS is rooted in our shared vision and commitment to accelerate the pace with which we ideate, create, and bring lifesaving innovations to cancer patients. A critical enabler of this will be harnessing the scale and expertise of the larger Amazon organization to advance our processes and infrastructure related to AI, inclusive of large language models,” said MSK Chief Strategy Officer Dr. Anaeze Offodile II.
Leveraging large language models through Amazon Bedrock and Amazon SageMaker relieves data quality constraints for AI model build; increases data density and speed through secure fine-tuning on cohorts of de-identified patient data; and provides proving grounds for AI model performance to build trust in model output. With this, MSK researchers and providers can better track how a patient’s cancer changes over time using computable disease trajectories. Combined with advanced tumor and clinical response predictions, this data-driven approach can help uncover new insights, personalize treatments, and improve patient care.
“Pairing MSK’s cancer research expertise and vast data resources from over a century of oncology care with AWS’s advanced cloud and AI capabilities creates a powerful engine for innovation,” said AWS Vice President of Worldwide Public Sector and Healthcare and Life Sciences Dave Levy. “MSK and AWS have a shared vision for applying technology to improve patient care and experience, and we’re excited about how this collaboration will accelerate patient-centered discovery and precision medicine for cancer.”
Find more innovation in business, from Stateside and beyond, here..
